CMA will not appeal after prochlorperazine ‘pay for delay’ fines overturned

A protracted prochlorperazine saga has ended after the Competition and Markets Authority (CMA) declined to appeal against the overturning of its fines against three companies by the Competition Appeal Tribunal (CAT).

“We are disappointed with this judgment,” a CMA spokesperson told C+D
James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

More from Regulation